System for long-term storage of pharmaceutical compositions
By using Luer lock connector and adapter in the syringe barrel system, combined with sealing members and coating design, the problem of insufficient syringe sealing integrity in the prior art is solved, and long-term storage stability of pharmaceutical compositions under extreme conditions is achieved Sex and safety.
Patent Information
- Application Number
- CN202380028080.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-07
- Filing Date
- 2023-04-05
- Publication Date
- 2024-11-01
AI Technical Summary
Existing connectors have defects in closed integrity in syringes that store pharmaceutical compositions for a long time, which can lead to leakage and contamination, especially underperforming at extreme temperatures.
Using a syringe barrel system including a cone and a plunger, the needle is fixed to the syringe barrel through a Luer lock connector, and the container closure integrity is improved by using the adapter and sealing member. The pull-off force and cone breaking force of the adapter are within a specific range. Combined coating and material design for enhanced sealing.
The long-term storage stability of the pharmaceutical composition is significantly improved under extreme temperature and humidity conditions, and the container sealing integrity of the system was verified by ISO 11040-4:2015 Appendix H test, ensuring the safety and effectiveness of the drug.
Smart Images

Figure CN118891072A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a system for long-term storage of pharmaceutical compositions, particularly including syringes. The system includes an adapter for securing a needle to a syringe barrel, thereby providing improved container closure integrity. Background Art
[0002] Prefilled syringes are often used as long-term storage systems for pharmaceutical compositions in a ready-to-use state. The pharmaceutical composition is filled into a syringe that is already equipped with a needle and a protective cap, which is also referred to in the relevant art as a needle shield. The needle shield often serves several purposes at the same time, namely: protecting the person handling the syringe from injury, protecting the needle and in particular the needle bevel from damage, and ensuring the sterility of the pharmaceutical composition in the syringe and the needle before use.
[0003] There are different connectors for securing needles to syringe barrels. However, existing connectors have proven themselves only partially suitable for long-term storage of pre-filled syringes with staked needles, especially at very low or very high temperatures (e.g. -80°C as required for some vaccines or 40°C and high humidity for tropical climates). There are obvious deficiencies in container closure integrity, i.e. the contents of the filled syringe may leak and / or become contaminated.
[0004] It is therefore an object of the present invention to overcome the disadvantages of the prior art and in particular to improve long term storage capability in terms of container closure integrity. Summary of the invention
[0005] The object of the invention is achieved by a system for the long-term storage of pharmaceutical compositions according to claim 1. Alternative embodiments are subject matter of the dependent claims.
[0006] In a first aspect, the present invention relates to a system for long-term storage of a pharmaceutical composition, the system comprising:
[0007] - a syringe barrel comprising:
[0008] + Includes the front end of the cone; and
[0009] +Backend;
[0010] - a plunger inserted into the rear end; and
[0011] - an adapter connected to the front end, the adapter comprising:
[0012] + Needles;
[0013] + an adapter body that connects the needle and the syringe barrel; and
[0014] +Optionally a needle shield, which covers the needle.
[0015] In a second aspect, the present invention relates to a system for long-term storage of a pharmaceutical composition, the system comprising:
[0016] - a syringe barrel comprising:
[0017] + Includes the front end of the cone; and
[0018] +Backend;
[0019] - a plunger inserted into the rear end; and
[0020] - an adapter connected to the front end, the adapter comprising:
[0021] + Needles;
[0022] + an adapter body that connects the needle and the syringe barrel; and
[0023] +Optionally a needle shield, which covers the needle;
[0024] The pull-off force of the adapter measured according to Appendix G.3 of ISO 11040-4:2015 is 1N to 500N.
[0025] In a third aspect, the present invention relates to a system for long-term storage of a pharmaceutical composition, the system comprising:
[0026] - a syringe barrel comprising:
[0027] + Includes the front end of the cone; and
[0028] +Backend;
[0029] - a plunger inserted into the rear end; and
[0030] - an adapter connected to the front end, the adapter comprising:
[0031] + Needles;
[0032] + an adapter body that connects the needle and the syringe barrel; and
[0033] +Optionally a needle shield, which covers the needle;
[0034] Wherein, the cone breaking force measured according to Appendix C.2 of ISO 11040-4:2015 is greater than 1N and / or less than 400N.
[0035] In a fourth aspect, the present invention relates to a system for long-term storage of a pharmaceutical composition, the system comprising:
[0036] - a syringe barrel comprising:
[0037] + Includes the front end of the cone; and
[0038] +Backend;
[0039] - a plunger inserted into the rear end; and
[0040] - an adapter connected to the front end, the adapter comprising:
[0041] + needles,
[0042] + an adapter body that connects the needle and the syringe barrel; and
[0043] +Optionally a needle shield, which covers the needle;
[0044] The pull-off force of the adapter measured according to Appendix G.3 of ISO 11040-4:2015 is 1 N to 500 N, and the cone breaking force measured according to Appendix C.2 of ISO 11040-4:2015 is greater than 1 N and / or less than 400 N.
[0045] One of the connectors used to attach the needle to the syringe is a Luer lock connector, which includes a cone on the barrel that is used to receive a corresponding receiving inner cone on the needle part. Both parts are fixed by means of an adapter. The adapter snaps onto the undercut of the cone and locks the needle in place. The inventors have found that during this snapping action, the surface and / or undercut area of the cone may be damaged by the retaining part with scratches or impact stress. This may lead to leakage during long-term storage, or in the worst case, to fracture of the cone, thereby reducing the container closure integrity.
[0046] On the other hand, however, the locking portion must be seated tightly enough on the cone to provide a certain minimum pull-off force of the needle and adapter for ensuring that the needle assembly is not accidentally removed when operating the prefilled syringe or pulling off the needle shield. In addition to this, the pressure exerted by the adapter also improves the container closure integrity by better sealing the contact surfaces, especially when used in combination with a resilient sealing member.
[0047] In some optional variations, the adapter may have a pull-off force of 50N to 400N, preferably 80N to 350N, more preferably 100N to 300N, more preferably 120N to 250N, more preferably 140N to 200N, and / or a cone breaking force of 5N or more, preferably 20N or more, more preferably 40N or more, more preferably 50N or more, more preferably 60N or more, and / or 300N or less, preferably 200N or less, more preferably 150N or less, measured according to Annex G.3 of ISO 11040-4:2015. The pull-off force of the adapter may be at least 50N, at least 60N, at least 70N, at least 80N, or at least 85N. The pull-off force of the adapter may be at most 50N to 400N, at most 300N, at most 250N, at most 200N, or at most 150N. The cone breaking force may be at least 5 N, at least 20 N, at least 40 N, at least 50 N, or at least 60 N. The cone breaking force may be at most 300 N, at most 200 N, or at most 150 N. The cone breaking force may be from 5 N to 300 N, or from 20 N to 200 N, or from 40 N to 200 N, or from 50 N to 150 N, or from 60 N to 150 N.
[0048] In a preferred embodiment, the system passes the container closure integrity test according to ISO 11040-4:2015 Annex H. In this test, the syringe is filled with liquid and immersed in a dye solution. Then, after a decompression / re-pressurization cycle, it is visually checked whether the dye solution has entered the syringe. The system according to the present disclosure passes this test performed with a freshly filled sample.
[0049] In an alternative embodiment, the system passes the container closure integrity test according to Annex H of ISO 11040-4:2015 after storage for a period of 7 days, preferably 30 days, more preferably 100 days, more preferably 3 months, more preferably 6 months, more preferably 1 year, more preferably 2 years, more preferably 5 years at ambient conditions of 15°C-30°C or at 40°C±2°C and 75%±5% relative humidity. This demonstrates the superior long-term storage performance of the system. Based on the conditions of the accelerated aging test as mentioned in the ICH guideline ICH Q1A ("Stability Testing of New Drug Substances and Products"), the filled syringes can be stored for a longer period of time before testing at room temperature and ambient conditions or even at high temperature and high humidity of 40°C and still pass the staining test.
[0050] In some embodiments of the system, the syringe barrel comprises or is made of glass; and / or the adapter body comprises a polymer.
[0051] In a further embodiment, the syringe barrel includes a shoulder, the cone includes a tapered region and an undercut portion, the tapered region includes the widest outer circumference of the cone, and the outer circumference of the undercut portion is smaller than the widest outer circumference of the cone, wherein preferably, the undercut portion is located between the tapered region and the shoulder of the syringe barrel.
[0052] In some embodiments, the adapter rotation resistance of the adapter on the cone can be 0.03Nm to 1Nm, preferably 0.04Nm to 0.6Nm, preferably 0.05Nm to 0.4Nm, preferably 0.06Nm to 0.3Nm. The adapter rotation resistance can be determined based on ISO 11040-4:2015 Appendix G.4. The adapter rotation resistance of the adapter on the cone can be at least 0.03Nm, at least 0.04Nm, at least 0.05Nm or at least 0.06Nm. The adapter rotation resistance of the adapter on the cone can be at most 1Nm, at most 0.6Nm, at most 0.4Nm or at most 0.06Nm to 0.3Nm. The adapter rotation resistance refers to the force required to rotate the adapter in its assembled state on the cone of the syringe around the longitudinal center axis of the syringe barrel. Therefore, the connection is anti-twist at a specified force level. This value indicates the tightness of the connection between the adapter and the cone. Therefore, it should not be too low.
[0053] In a further embodiment, the adapter is anti-tiltingly mounted to the syringe barrel so that the central axis of the needle is aligned with the central axis of the syringe barrel. This means that when the adapter is mounted to the syringe barrel, the possibility of its sideways tilting is sufficiently limited so that the needle remains on the central axis of the syringe barrel. This is particularly important to avoid damaging the needle bevel when the needle shield is placed on the syringe.
[0054] In an embodiment, the needle is fixedly mounted or removably mounted in the adapter body. In its simplest form, the needle is fixedly mounted in the adapter body. By maintaining the orientation of the needle in line with the syringe barrel, the needle can also be designed to be movable along the longitudinal axis of the adapter. This design allows the construction of a disposable syringe to retract the needle to prevent secondary use. Both options are suitable for the function of the adapter design of the present disclosure.
[0055] The adapter body may comprise a first portion supporting the needle and a second portion in contact with the cone, preferably with the undercut of the cone. Thus, the adapter body is not a single piece but is assembled from two separate parts, one of which holds the needle and the second of which establishes the connection with the syringe barrel.
[0056] In some embodiments, the first part and the second part are preferably irreversibly connected by a snap-fit mechanism. In particular, this connection is not only achieved by a screw connection. A snap-fit mechanism refers to a connection established by means of a form fit that performs a snapping action and locks the parts. Thus, an obstacle to the translational movement is generated in the force direction of the rotation axis of the system.
[0057] Optionally, the setting force of the second part of the adapter on the cone and / or the setting force of the adapter on the cone and / or the force of irreversibly connecting the first part and the second part to reach the engaging point of the engaging mechanism by the engaging mechanism is 10N to 300N, preferably 20N to 150N, more preferably 50N to 120N. The setting force for the adapter to reach the engaging point of the engaging mechanism can be at least 10N, at least 20N or at least 50N. The setting force for the adapter to reach the engaging point of the engaging mechanism can be at most 300N, at most 150N or at most 120N. The setting force to reach the engaging point is the force required to press these parts together until they bite together and lock. These values can be predefined on the setting machine. By using a method control system, the force needs to be within a specified range. By using a force control system, the force will be adjusted within a given range to complete the setting process. When the second part is pushed to the undercut of the cone, the setting process is completed. The assembly process may include first assembling the first and second parts and then assembling the entire adapter with the syringe barrel, or first assembling the second part with the syringe barrel and then assembling the first part with the already installed second part.
[0058] In an embodiment, the material of the second portion comprises or consists of a polymer.
[0059] In an embodiment, a sealing member is arranged between the first part and the syringe barrel. Since the sealing member seals the connection between the needle and the syringe barrel, it is important for the container closure integrity. By changing the characteristics of the sealing member, the assembly and sealing process can be optimized. It is particularly advantageous to adjust the characteristics of the sealing member with respect to the expected setting force and adapter retention and rotation resistance.
[0060] In an alternative variant, the sealing member is in contact with the cone, preferably with the end portion of the cone, which is located at the distal end side of the syringe barrel. This achieves a very effective seal and allows the compression of the sealing member to be selected.
[0061] In a further embodiment, the Shore A hardness of the sealing member measured for 10 seconds according to ASTM D2240:2021 is 20 to 80, preferably 30 to 70, more preferably 45 to 65, more preferably 55 to 60. The Shore A hardness of the sealing member may be at least 20, at least 30, at least 45, or at least 55. The Shore A hardness of the sealing member may be at most 80, at most 70, at most 65, or at most 60. This range has been found to be optimal for sealing performance and compression performance.
[0062] In some embodiments, the sealing member is at least partially compressed by the snap-fit mechanism, preferably at least partially compressed by 10% to 80%, preferably 20% to 70%, more preferably 30% to 60%, more preferably 40% to 50%. The sealing member can be compressed by the snap-fit mechanism by at least 10%, at least 20%, at least 30% or at least 40%. The sealing member can be compressed by the snap-fit mechanism by at most 80%, at most 70%, at most 60% or at most 50%. This can obtain good results in terms of the sealing, stability and integrity of the connection between the adapter and the syringe barrel. The mechanical compression behavior can be determined via nonlinear finite element simulation. The material model reproduces the nonlinear stress-strain behavior of the material and distinguishes between uniaxial and multiaxial loading. The simulation model is composed of solid elements, and each element has at least four integration points. The feature of the FE grid is a minimum of 50 elements on the thickness of the body. In the simulation, towards the level defined by the technical design, the cone is pressed onto the sealing member. The maximum true strain generated by the sealing member is measured.
[0063] In a further embodiment, the Young's modulus of the sealing member determined according to ISO 527-1 / -2:2019 is 0.1 MPa to 5 MPa, preferably 1 MPa to 4 MPa, more preferably 1.5 MPa to 3 MPa. The Young's modulus of the sealing member may be at least 0.1 MPa, at least 1 MPa or at least 1.5 MPa. The Young's modulus of the sealing member may be at most 5 MPa, at most 4 MPa or at most 3 MPa.
[0064] Young's modulus can be determined with a test setup according to ISO 527-1 / -2:2019. Sample geometry 5A or 5B can be used. In addition, a 3D camera system (e.g. GOM ARAMIS12M) can be used in order to measure local surface strains via digital image correlation (DIC). At least 100 images of the ongoing test must be recorded. The end of the test is sample failure. Measurement of true strain / Hencky strain (ε 真实,横向 ). In DIC, a minimum of 100 overlaps are required across the width of the specimen. The force is measured by a material testing machine (load cell ≤ 5 kN). The strain information from DIC must be on the same time axis as the force signal. It is assumed that the transverse strain is equal in both transverse directions. The true stress is calculated by the following formula:
[0065]
[0066] Young's modulus was determined as the initial slope in the stress-strain diagram.
[0067] In an embodiment, the thickness of the sealing member in its compressed state is preferably 0.05mm to 3.00mm, preferably 0.5mm to 2.50mm, preferably 0.80mm to 2.20mm. The thickness refers to the size of the sealing member parallel to the central axis of the needle and the syringe barrel when assembled. The thickness of the sealing member in its compressed state can be at least 0.05mm, at least 0.5mm or at least 0.80mm. The thickness of the sealing member in its compressed state can be at most 3.00mm, at most 2.50mm or at most 2.20mm. The thickness in the uncompressed state can be determined by a caliper. The mechanical compression behavior can be determined via nonlinear finite element simulation. The material model reproduces the nonlinear stress-strain behavior of the material and distinguishes between uniaxial and multiaxial loading. The simulation model consists of solid elements, each of which has at least four integration points. The FE grid is characterized by a minimum of 50 elements on the thickness of the body. In the simulation, toward the level defined by the technical design, the cone is pressed onto the sealing member.
[0068] In a further embodiment, the material of the sealing member comprises a polymer, preferably consists of a polymer, which is preferably an elastomer, more preferably a thermoplastic elastomer. In particular, thermoplastic elastomers provide the advantages of moldability through injection molding combined with elasticity for achieving good sealing.
[0069] In other embodiments, the second portion is a retaining portion.
[0070] In an embodiment, the second part is substantially annular in shape, which is not completely closed and / or has a gap and / or whose diameter can widen. This reduces the forces exerted on the cone and the undercut during assembly of the system. An option for ease of assembly, without damaging the cone or the undercut, is to be able to insert a wedge-shaped member in the gap, which can be removed by means of a lug after sliding the second part over the cone.
[0071] In an embodiment, the second portion is substantially annular in shape, which exerts a spring force in the direction of its central axis. The central axis here refers to an axis perpendicular to the diameter of the annular shape. When assembled on a syringe, this spring force acts on the undercut of the cone along the central axis of the syringe barrel and elastically pulls the adapter towards the cone. This can improve the container closure integrity, especially when used at very low or high temperatures.
[0072] In some embodiments, after removal of the second part and elastic relaxation, the ratio of the inner circumference of the second part to the widest outer circumference of the cone is between 85% [mm / mm] and 99% [mm / mm] or between 90% [mm / mm] and 99% [mm / mm] when determined by measuring the inner diameter of the second part with the aid of a visual measuring device. The inner diameter of the second part is measured after its plastic deformation during assembly. For the measurement, the cone can be broken and the second part can be removed for elastic relaxation. The inner diameter can be determined using an optical microscope (e.g. Optometron UI-1540-C).
[0073] In some embodiments, after removal of the second part and elastic relaxation, the ratio of the inner circumference of the second part to the circumference of the undercut of the cone is 90% [mm / mm] up to 107% [mm / mm] when determined by measuring the inner diameter of the second part with the aid of a visual measuring device. The inner diameter of the second part is measured after its plastic deformation during assembly. For the measurement, the cone can be broken and the second part can be removed for elastic relaxation. Using an optical microscope (e.g. Optometron UI-1540-C), the inner diameter can be determined.
[0074] In a further embodiment, the ratio of the radial force of the second part to the pull-off force of the adapter is 1% to 20,000% [N / N], preferably 2% to 5,000% [N / N], more preferably 5% to 200% [N / N], more preferably 10% to 100% [N / N], more preferably 20% to 50% [N / N]. The ratio may be at least 1% [N / N], at least 2% [N / N], at least 5% [N / N], at least 10% [N / N] or at least 20% [N / N]. The ratio may be at most 20,000% [N / N], at most 5,000% [N / N], at most 200% [N / N], at most 100% [N / N] or at most 50% [N / N]. The radial force refers to the force exerted by the second part, which is substantially annular in shape, in its radial direction and in the assembled state.
[0075] In an embodiment, the radial force of the second portion is 5N to 200N, preferably 10N to 180N, more preferably 20N to 150N, more preferably 30N to 120N, more preferably 40N to 100N, more preferably 50N to 80N. The radial force of the second portion can be at least 5N, at least 10N, at least 20N, at least 30N, at least 40N or at least 50N. The radial force of the second portion can be at most 200N, at most 180N, at most 150N, at most 120N, at most 100N or at most 80N. In order to determine the radial force, the second portion can be simulated via nonlinear finite element simulation. The simulation model is composed of solid elements (quadrilaterals), and each element has at least four integration points. The feature of the FE grid is the minimum ten elements on the thickness of the body. The second portion is widened to the maximum diameter of the cone of the syringe barrel, and then relaxed to the circumference of the undercut. The reaction force generated is measured in the radial direction.
[0076] In a further embodiment, the pull-off force of the adapter is the pulling force of the second part. This means that the force for attaching the adapter to the syringe barrel is provided by the second part only. No other parts are required for this purpose.
[0077] In an embodiment, the material of the second part comprises metal, preferably consists of metal, preferably a metal comprising iron and / or aluminum, more preferably stainless steel. These materials provide good holding function and durability, and can be easily stamped into a desired shape.
[0078] In a further embodiment, the thickness of the second portion is 0.03mm to 1mm, preferably 0.05mm to 0.8mm, more preferably 0.1mm to 0.4mm, more preferably 0.15mm to 0.3mm. The thickness of the second portion can be at least 0.03mm, at least 0.05mm, at least 0.1mm or at least 0.15mm. The thickness of the second portion can be at most 1mm, at most 0.8mm, at most 0.4mm or at most 0.3mm. In this case, thickness refers to the thickness of the flat material in the axial direction of the second portion of the basic annular shape, i.e., not considering the external dimensions of the three-dimensional shape portion. Thickness can be measured via caliper (resolution / precision ± 0.001mm). Repeat measurement at least five different positions of calculating the arithmetic mean.
[0079] In an embodiment, the ratio of the Young's modulus [GPa] determined according to ISO 527-1 / -2:2019 to the thickness [mm] of the second portion is 50 to 10,000 [GPa / mm], preferably 100 to 8,000 [GPa / mm], preferably 200 to 5,000 [GPa / mm], preferably 300 to 2,000 [GPa / mm], preferably 500 to 1,000 [GPa / mm]. The ratio may be at least 50 [GPa / mm], at least 100 [GPa / mm], at least 200 [GPa / mm], at least 300 [GPa / mm] or at least 500 [GPa / mm]. This ratio may be at most 10,000 [GPa / mm], at most 8,000 [GPa / mm], at most 5,000 [GPa / mm], at most 2,000 [GPa / mm] or at most 1,000 [GPa / mm]. This ratio has been found to provide the second portion with the best mechanical properties in relation to its size and the retention function achieved.
[0080] In some embodiments, the second portion is completely surrounded by the first portion and / or the second portion is embedded in the first portion.
[0081] In order to reduce damage to the cone and the undercut, the thickness of the lug of the second part of the substantially annular shape can be set relative to the width of the lug measured along the inner circumference. Depending on the material used, the ratio of the width of the lug measured along the inner circumference to the thickness of the lug should range from 1 [mm / mm] to 450 [mm / mm], preferably from 2 [mm / mm] to 100 [mm / mm], more preferably from 3 [mm / mm] to 50 [mm / mm], more preferably from 4 [mm / mm] to 20 [mm / mm]. The ratio may be at least 1 [mm / mm], at least 2 [mm / mm], at least 3 [mm / mm] or at least 4 [mm / mm]. The ratio may be at most 450 [mm / mm], at most 100 [mm / mm], at most 50 [mm / mm] or at most 20 [mm / mm].
[0082] Further, for optimization, the length of the slot in the lug and the angle of the lug relative to the central axis of the ring can be varied. For best results, the length of the slot should range from 0 mm to 3 mm, preferably from 0.1 mm to 2 mm, more preferably from 0.4 mm to 0.8 mm. The length may be at least 0 mm, at least 0.1 mm or at least 0.4 mm. The length may be at most 3 mm, at most 2 mm or at most 0.8 mm.
[0083] In other embodiments, the cone and / or the second part comprises at least one area coated by a single or multilayer coating. Optionally, the cone comprises a coating. The multilayer coating may comprise multiple layers of the same coating material, i.e. a single material is applied repeatedly in thinner layers or layers of different coating materials. The latter is particularly suitable for providing different functions to the coating, such as a damping effect and an anti-scratch effect or a surface defect sealing effect. In the case where the cone and the second part are coated, different functions may also be applied to them respectively. For example, the second part may be provided with a damping coating and the cone may be provided with an anti-scratch and / or surface defect sealing coating.
[0084] In an embodiment, at least one region comprises a tapered region and / or an undercut of the cone, preferably an undercut, the tapered region having the widest outer circumference of the cone. The tapered region and in particular the undercut are the most critical regions with respect to damage and leakage. They can be effectively protected by a suitable coating to improve long-term container closure integrity.
[0085] In an embodiment, the coating reduces surface imperfections on the cone and / or reduces the impact when the second part snaps onto the cone. A properly coated cone is more resistant to scratching by the mating second part and reduces the impact of the retaining mechanism snapping into the undercut. The same applies to the coating on the second part, which gives a less scratchy surface property and a damping effect.
[0086] In an embodiment, the coating comprises a polymer and / or a ceramic, the polymer being in particular an elastomer and / or a thermoplastic and / or a thermoset and / or a silicone.
[0087] In some embodiments, the coating includes nitrocellulose lacquer, polytetrafluoroethylene, silicone oil, silicone polymer, acrylic paint, (hydroxyethyl) methacrylate lacquer, shellac, epoxy resin and / or screen printing ink. The silicone oil can be a mixture of different molecular weights and / or different monomer units (such as polydimethylsiloxane or polydiphenylsiloxane, including their copolymers) and / or different end groups. This is very beneficial for fine-tuning the characteristics of the coating and adapting to certain processes (such as dip coating or spraying). For example, when the cone is dip coated, a suitable oil viscosity can be selected and the thickness of the formed coating can be set by the immersion time. In addition, these specific coating media have proven that they can effectively suppress the impact on the glass by themselves, while having sufficient scratch resistance to prevent the formation of dust particles, which may be harmful in medical applications. Another advantage of them is that they can be applied on untreated surfaces and still obtain good adhesion.
[0088] Optionally, the silicone oil mixture may include a cross-linked polysiloxane matrix. This refers to the coating after the silicone oil mixture is applied and the desired cross-linking step is finally completed. Optionally, based on the total weight of the silicone oil mixture, the total content of the cross-linked polysiloxane matrix is in the range of 50wt.% to 90wt.%, preferably in the range of 60wt.% to 80wt.%, more preferably in the range of 65wt.% to 75wt.%.
[0089] The silicone oil mixture can be prepared from a mixture comprising one or more (preferably all) of the following:
[0090] - reactive polysiloxanes;
[0091] - non-reactive polysiloxanes;
[0092] - a catalyst; and
[0093] -Thinner.
[0094] The reactive polysiloxane may be adapted to be arranged to undergo a crosslinking reaction to obtain a crosslinked network. The crosslinking may be catalyzed by a catalyst.
[0095] The reactive polysiloxane may comprise vinyl and / or silane functional groups. These functional groups may be present in a single polymer chain or in different polymer chains, i.e. in this case the reactive polysiloxane is a mixture of different polysiloxanes. The reactive polysiloxane may also be a block copolymer comprising one or more non-functionalized blocks and one or more functionalized blocks.
[0096] The reactive polysiloxane may include a mixture of vinyl functionalized polydialkylsiloxanes (particularly vinyl functionalized polydimethylsiloxanes) and random or block copolymers comprising dialkylsiloxane monomer units and alkylhydrogensiloxane monomer units (particularly dimethylsiloxane monomer units and methylhydrogensiloxane monomer units). All of these variations of reactive polysiloxanes provide a convenient means for adjusting the degree of crosslinking and the mechanical properties of the resulting coating.
[0097] Non-reactive polysiloxanes are particularly incapable of crosslinking reactions. In some embodiments, non-reactive polysiloxanes may include one or more alkyl groups. Optionally, one or more alkyl groups in polyalkylsiloxanes or polydialkylsiloxanes are independently selected from branched or unbranched C1 to C8 alkyl groups. The alkyl group may be a straight chain alkyl group. For example, the alkyl group may be independently selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl and octyl. Optionally, the alkyl group is independently selected from methyl and ethyl. Another non-reactive polysiloxane may be completely substituted with an alkyl group. An optional non-reactive polysiloxane is polydimethylsiloxane.
[0098] The coating may include more than one type of non-crosslinked non-reactive polysiloxane, such as at least two types or at least three types of non-crosslinked non-reactive polysiloxane. The viscosities of these types may be different. In some embodiments, the coating includes a high viscosity non-crosslinked non-reactive polysiloxane having a viscosity of more than 10,000 cSt, and / or a low viscosity non-crosslinked non-reactive polysiloxane having a viscosity of less than 10,000 cSt. The viscosity may be determined according to DIN EN ISO 3219:1993 at 23°C and 10 s -1 Optionally, the viscosity of the high viscosity non-crosslinked non-reactive polysiloxane is at least 15,000 cSt, and / or the viscosity of the low viscosity non-crosslinked non-reactive polysiloxane is 5,000 cSt or less.
[0099] Optionally, the weight average molecular weight of the low viscosity non-crosslinked non-reactive polysiloxane is 1,200 g / mol to 30,000 g / mol, and / or the weight average molecular weight of the high viscosity non-crosslinked non-reactive polysiloxane is 15,000 g / mol to 300,000 g / mol. The weight average molecular weight can be determined according to DIN EN ISO 13885-1:2021-11 using a polystyrene standard. In one embodiment, the weight average molecular weight of the high viscosity non-crosslinked non-reactive polysiloxane is 32,000 g / mol to 210,000 g / mol, or 100,000 g / mol to 150,000 g / mol. In one embodiment, the weight average molecular weight of the low viscosity non-crosslinked non-reactive polysiloxane is 5,000 g / mol to 25,000 g / mol, or 10,000 g / mol to 20,000 g / mol.
[0100] In embodiments, the low viscosity non-crosslinked non-reactive polysiloxane has a weight average molecular weight of at least 1,200 g / mol, at least 5,000 g / mol, or at least 10,000 g / mol. The weight average molecular weight may be up to 30,000 g / mol, up to 25,000 g / mol, or up to 20,000 g / mol.
[0101] In embodiments, the high viscosity non-crosslinked non-reactive polysiloxane has a weight average molecular weight of at least 15,000 g / mol, at least 32,000 g / mol, or at least 100,000 g / mol. The weight average molecular weight may be up to 300,000 g / mol, up to 210,000 g / mol, or up to 150,000 g / mol.
[0102] In some embodiments, the ratio of the weight of the cross-linked reactive polysiloxane to the weight of the non-cross-linked non-reactive polysiloxane in the coating is less than 3.00, less than 2.50, less than 1.80, or less than 1.20. The ratio of the weight of the cross-linked reactive polysiloxane to the weight of the non-cross-linked non-reactive polysiloxane in the coating can be at least 0.40, at least 0.60, or at least 0.70. In embodiments, the ratio ranges from 0.40 to 3.00, 0.60 to 2.50, or 0.70 to 1.80. The non-cross-linked non-reactive polysiloxane can help achieve the desired elasticity.
[0103] An optional catalyst can catalyze the reaction to crosslink the polysiloxane. For example, platinum can be used as a catalyst for the hydrosilylation reaction between vinyl and hydrogen substituents of the polysiloxane.
[0104] The optional diluent may dissolve one or more other ingredients in the mixture. The diluent may be silicon-based. The diluent may be a short chain polysiloxane, optionally having 6 or fewer repeating units.
[0105] In an embodiment, the diluent may be: i) a cyclosilicone, in particular octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, tetramethylcyclotetrasiloxane, pentamethylcyclopentasiloxane; ii) hexamethyldisiloxane (HMDSO); iii) octamethyltrisiloxane; and iv) decamethyltetrasiloxane. An optional diluent is hexamethyldisiloxane. Mixtures of the above diluents may also be used.
[0106] In some silicone oil mixtures, the content of diluent in the mixture can be greater than 45wt.% and less than 95wt.%, optionally more than 45wt.% and less than 95wt.%, more preferably greater than 50wt.% and less than 95wt.%, more preferably greater than 55wt.% and less than 95wt.%, more preferably greater than 60wt.% and less than 95wt.%, more preferably greater than 65wt.% and less than 95wt.%, more preferably greater than 70wt.% and less than 95wt.%, more preferably greater than 75wt.% and less than 95wt.%, more preferably greater than 80wt.% and less than 90wt.%, and most preferably greater than 83wt.% and less than 88wt.%.
[0107] Some silicone oil mixtures optionally have a water content of no more than 10 wt.%, optionally no more than 5 wt.%, or no more than 1 wt.%, based on the total weight of the silicone oil mixture.
[0108] In a further embodiment, the coating has a thickness, preferably an average thickness, of 40 nm to 200 μm, preferably 70 nm to 60 μm, preferably 80 nm to 50 μm, preferably 90 nm to 40 μm. The coating may have a thickness of at least 40 nm, at least 70 nm, at least 80 nm or at least 90 nm. The coating may have a thickness of at most 200 μm, at most 60 μm, at most 50 μm or at most 40 μm. The coating thickness can be determined by measuring with a spectroscopic interferometer (e.g., Hamamatsu Optical NanoGauge).
[0109] In an embodiment, when a silicone oil mixture is used as a coating, the coating has a thickness, optionally an average thickness, of 0.05 μm to 40 μm, more preferably 0.1 μm to 10 μm, more preferably 0.5 μm to 5 μm. The thickness may be at least 0.05 μm, at least 0.1 μm or at least 0.5 μm. The thickness may be at most 40 μm, at most 10 μm or at most 5 μm.
[0110] In some embodiments, the thickness of the coating on the cone has a gradient in a direction along the cone. When viewed from the tip of the syringe toward the barrel, the gradient can be such that the thickness increases or decreases along the cone, preferably increases. Since the force exerted by the retaining structure on the surface of the cone increases with the diameter of the cone, more protection is required at the thicker end of the cone, while at the thinner end of the cone, the coating can be formed thinner to reduce the resistance to the movement of the components and thus make the force required to attach the adapter less. Thus, for example, an inverse gradient can be used to balance the force required to move the adapter.
[0111] In an embodiment, the ratio of the pull-off force [N] to the thickness of the coating [nm] is 0.0004 to 8.75 [N / nm], preferably 0.0005 to 4 [N / nm], more preferably 0.0025 to 1 [N / nm], more preferably 0.01 to 0.1 [N / nm]. The ratio may be at least 0.0004 [N / nm], at least 0.0005 [N / nm], at least 0.0025 [N / nm] or at least 0.01 [N / nm]. The ratio may be at most 8.75 [N / nm], at most 4 [N / nm], at most 1 [N / nm] or at most 0.1 [N / nm].
[0112] In a further embodiment, the ratio of the hardness of the glass expressed in MPa Young's modulus determined according to ISO 527-1 / -2:2019 to the hardness of the coating expressed in MPa Young's modulus determined according to ISO 527-1 / -2:2019 is 4 to 10,000 [MPa / MPa], preferably 10 to 1,000 [MPa / MPa], preferably 20 to 500 [MPa / MPa], preferably 40 to 200 [MPa / MPa], preferably 60 to 100 [MPa]. The ratio may be at least 4 [MPa / MPa], at least 10 [MPa / MPa], at least 20 [MPa / MPa], at least 40 [MPa / MPa] or at least 60 [MPa / MPa]. The ratio may be at most 10,000 [MPa / MPa], at most 1,000 [MPa / MPa], at most 500 [MPa / MPa], at most 200 [MPa / MPa], or at most 100 [MPa / MPa].
[0113] In some embodiments, the adhesive force in the coating is less than the adhesion force of the coating on the glass or polymer surface. The adhesive force and / or adhesion force can be determined according to DIN EN ISO 4624:2016-08 and ASTM D4541-22. By selecting the coating material accordingly, a double advantage can be generated. The first advantage is that when the retaining structure slides on the coated surface to bite behind the undercut to fix the adapter in place, at least a certain amount of protective coating will be retained on the surface because the coating is easier to separate from the coated glass or polymer surface of the syringe in itself. Therefore, even if the shearing action of the structure is too high and the coating cannot remain intact, a protective effect can still be provided. The second advantage is particularly relevant to polymer coatings, where it can be used in the following design: in this design, the moving retaining structure will scrape a small amount of coating from the surface and transport it in bulk along the cone like a snow plow to the front of its front. Once the undercut is reached, the accumulated bulk will additionally cushion the impact and especially fill the gap between the retaining structure and the syringe surface caused by the different manufacturing tolerances of the two parts. The latter will avoid peak impacts on the surface and spread the force more evenly across the surface. BRIEF DESCRIPTION OF THE DRAWINGS
[0114] Figure 1 is a cross-sectional view of an adapter body in its assembled state including a connected first part and a second part.
[0115] Figure 2 is a cross-sectional view of an adapter body comprising a connected first part and a second part in its assembled state, the adapter body comprising a needle and a sealing member.
[0116] Figure 31 and 2 are a top view and a perspective view of the second part, which is substantially in the shape of an annulus with a gap.
[0117] Figure 4a and 4b is a perspective view of a detail of the second portion of the ring shape.
[0118] Figure 5 is a cross-sectional view of a syringe barrel with a cone and a coating thereon.
[0119] Figure 6 is a perspective view of the second portion of the coated annular shape. DETAILED DESCRIPTION
[0120] Figure 1 A first example of an adapter body according to the invention is shown in FIG. In a cross-sectional view, an adapter body is shown comprising a first part (1) and a second part (2) connected in its assembled state. Within the first part (1), a sealing member area (3) for receiving a sealing member (5) is shown by a dashed line, which sealing member 5 is not shown in the figure. The sealing member (5) is used to seal the connection between a needle (6) (which is also not shown) to be inserted into the first part (1) and the cone of the syringe barrel to be inserted through the second part (2). During the assembly of the syringe, the first part (1) and the second part (2) are snapped together and locked by means of a locking part (4). The second part (2) first slides over the cone of the syringe barrel and locks on the undercut (8) of the cone with the smaller diameter hole on the left side of the figure. Then, the first part (1) comprising the needle (6) and the sealing member (5) is slid onto the second part (2) and the connection with the cone, in particular the connection with the undercut (8), is stabilized. The softer material of the second part (2) avoids damage to the cone and the undercut (8), while the harder first part (1) thereafter ensures the stability required for the connection. In a variant of the example, the two materials can also be identical.
[0121] The second example is Figure 2 As shown. In this embodiment, the second part (2) is a retaining ring element inserted into the base of the first part (1). The needle (6) is fixed in the upper end of the first part (1) and is surrounded by the sealing member (5) in the sealing member area (3). For assembly, the annular shaped second part (2) and the sealing member (5) are inserted into the base and the tip of the first part (1) respectively, and then the assembled adapter is pushed onto the cone of the syringe barrel.
[0122] Figure 3A top view and a perspective view of the corresponding second part (2) are shown, which is essentially annular in shape with a gap. This version can be used directly and exerts less force on the cone and the undercut. Or it can be sized so that its inner diameter is closer to the outer diameter of the undercut (8) and used with a wedge member inserted in the gap. After pushing the adapter assembly over the cone to the undercut, the wedge member is removed to tighten the connection.
[0123] Figure 4a and Figure 4b A further variation of the substantially annular second portion (2) is shown in FIG. In order to reduce damage to the cone and the undercut (8), the thickness of the lug (12) of the substantially annular second portion (2) can be set relative to the width of the lug (12) measured along the inner circumference, as indicated by the dashed outline and arrows in the figure. In this example, the ratio of the width of the lug (12) measured along the inner circumference to the thickness of the lug (12) is 18 [mm / mm]. Figure 4b As shown, the length of the slot (13) in the lug (12) (indicated by two arrows and a dotted line) can be varied for optimization. In the example shown, the length of the slot (13) is 0.6 mm to obtain the best results.
[0124] Figure 5 A third example is shown, the Figure 5 A cross-sectional view of a syringe barrel with a cone and coating thereon. Only the top end of the barrel is shown. The tip of the syringe barrel is formed by a cone comprising a tapered area (7) and an undercut (8) which then leads into the area of a shoulder (9) leading to the barrel cylinder. Figure 5 , the coating on the coated area (10) of the tapered region and the coated area (11) of the undercut is shown. The coated area (10) of the tapered region is coated with a scratch resistant thermoplastic coating, and the coated area (11) of the undercut is coated with a damping silicone coating.
[0125] Figure 6 A perspective view of the coated annular shaped second part (2) is shown. The entire second part (2) is covered with a silicone coating.
[0126] Experimental Results
[0127] coating
[0128] The different coatings have been studied with respect to their protective properties and characteristics. For comparison, they were all applied to the same type of standard Luer cone syringe made of glass as described in ISO 11040-4:2015. Figure 7 As shown, the coating is applied only to the coated area (11) of the undercut.
[0129] The silicone oil mixture used for coating was a curable four-component mixture, as described above, which was applied by dip coating at an average thickness of 700 nm.
[0130] The (hydroxyethyl) methacrylate paint was applied by brushing with a thickness of 0.0395 mm.
[0131] a) Luer cone fracture resistance test (ISO11040-4:2015 Appendix C.2)
[0132] For reference purposes, the cone breaking force of a standard Luer cone syringe made of glass with and without an adapter has been determined in a Luer cone fracture resistance test according to ISO 11040-4:2015 Annex C.2 (force transmission point: 2 mm from the tip of the syringe barrel). The measured statistics are based on a set of 30 syringes, which were tested for reference. Thereafter, the coated area of the undercut of the cone of other sets of syringes of the same type have been coated with the corresponding coating and tested. The measured statistics are based on a set of 10 syringes, which were tested for the coated specimens. The results are summarized in the following table:
[0133]
[0134]
[0135] 1 The cone break measurement performed with the setup according to ISO 11040-4:2015 Annex C.2 (force transfer point: 2 mm from the tip of the syringe barrel) results in a bending of the polymer cone of the adapter here. The measurement for (hydroxyethyl)methacrylate was therefore performed with the force transfer point moved to 5.5 mm from the tip of the syringe barrel. For the normal ISO 11040-4:2015 Annex C.2 setup (with a distance of 2 mm), it could be determined that the cone break value was at least higher than the maximum bending value measured, which was 75.76 N.
[0136] b) Dye solution air tightness test (ISO11040-4:2015 Appendix H)
[0137] The known method for determining the airtightness of a container is the so-called dye solution airtightness test, which is set forth in the Appendix H of the third edition, Part 4, of the international standard ISO 11040 issued on April 1, 2015. According to this standard, a subassembly syringe filled with liquid and sealed with a plunger stopper is immersed in a dye solution that is generally aqueous. After the decompression / repressurization cycle, the leakage of the subassembly syringe is checked by checking whether the dye solution enters the syringe. For this reason, the dye solution is placed in a vacuum chamber together with the syringe immersed therein, and the vacuum chamber produces and maintains a negative pressure of at least 270mbar within half an hour. In the case of leakage in one of the containers, a part of the contents still under atmospheric pressure in the container will be pressed out by leakage. Afterwards, when the vacuum chamber is repressurized, a part of the dye solution is pressed into the container by leakage by ambient pressure to compensate for the volume of the contents previously pressed out. This dye can be detected using optics or spectroscopy techniques subsequently.
[0138] In an alternative approach, the gas transfer that occurs during the decompression / recompression cycle between the air in the headspace of the container and a reference gas (e.g., carbon dioxide) in the vacuum chamber is detected. Since the reference gas is generally invisible, subsequent inspection of the container is primarily performed by means of spectroscopy to thereby detect anomalous gas compositions or concentrations of the reference gas in the headspace.
[0139] Test results are indicated by a pass or fail rating.
[0140]
[0141] c) Setting force test (similar to ISO 11040-4:2015 Annex H)
[0142] The setting force measured here is the force required to irreversibly connect the adapter to the cone of the syringe barrel via a snap-fit mechanism. Similar to ISO 11040-4:2015 Annex H, the setting force can be determined by pushing rather than pulling at a speed of 100 mm / min.
[0143]
[0144] d) Pull-off force test (ISO 11040-4:2015 Appendix G.3)
[0145] In the pull-off force test, the force required to pull the attached adapter out of the cone of the syringe is measured.
[0146] The pull-off force can be determined according to ISO 11040-4:2015 Annex G.3.
[0147]
[0148] This public project
[0149] The present disclosure is characterized by one or more of the following items.
[0150] Item 1. A system for long-term storage of a pharmaceutical composition, the system comprising:
[0151] - a syringe barrel comprising:
[0152] + Includes the front end of the cone, and
[0153] +Backend;
[0154] - a plunger inserted into said rear end; and
[0155] - an adapter connected to said front end, the adapter comprising:
[0156] + Needles;
[0157] + an adapter body that connects the needle and the syringe barrel; and
[0158] +optionally a needle shield covering the needle;
[0159] in,
[0160] - the pull-off force of the adapter measured according to ISO 11040-4:2015 Annex G.3 is between 1N and 500N; and
[0161] - The cone breaking force measured according to ISO 11040-4:2015 Annex C.2 is 1 N or more and / or 400 N or less.
[0162] Item 2. The system according to Item 1, wherein:
[0163] - the pull-off force of the adapter measured according to ISO 11040-4:2015 Annex G.3 is 50N to 400N, preferably 60N to 300N, more preferably 70N to 250N, more preferably 80N to 200N, more preferably 85N to 150N; and / or
[0164] - The cone breaking force measured according to ISO 11040-4:2015 Annex C.2 is 5N or more, preferably 20N or more, more preferably 40N or more, more preferably 50N or more, more preferably 60N or more and / or 300N or less, preferably 200N or less, more preferably 150N or less.
[0165] Item 3. A system according to Item 1 or 2, wherein the system passes the container closure integrity test according to Annex H of ISO 11040-4:2015.
[0166] Item 4. A system according to Item 3, wherein the system passes the container closure integrity test according to Annex H of ISO 11040-4:2015 after storage for 7 days, preferably 30 days, more preferably 100 days, more preferably 3 months, more preferably 6 months, more preferably 1 year, more preferably 2 years, and more preferably 5 years under environmental conditions of 15°C-30°C or at 40°C±2°C and 75%±5% relative humidity.
[0167] Item 5. A system according to any one of the preceding items, wherein:
[0168] - the syringe barrel comprises glass, preferably is made of glass; and / or
[0169] - The adapter body comprises a polymer.
[0170] Item 6. The system of any of the preceding items, wherein the syringe barrel comprises:
[0171] - shoulders; and
[0172] - wherein the cone comprises:
[0173] + a conical region comprising the widest outer circumference of the cone; and
[0174] + an undercut having an outer circumference smaller than the widest outer circumference of the cone, wherein preferably the undercut is located between the tapered area and the shoulder of the syringe barrel.
[0175] Item 7. A system according to any of the preceding items, wherein the adapter rotation resistance of the adapter on the cone is 0.03Nm to 1Nm, preferably 0.04Nm to 0.6Nm, preferably 0.05Nm to 0.4Nm, preferably 0.06Nm to 0.3Nm.
[0176] Item 8. The system according to any one of the preceding items, wherein the adapter is anti-tilt mounted to the syringe barrel so that the central axis of the needle is consistent with the central axis of the syringe barrel.
[0177] Item 9. The system according to any of the preceding items, wherein the needle is fixedly mounted or movably mounted within the adapter body.
[0178] Item 10. The system of any of the preceding items, wherein the adapter body comprises:
[0179] - a first portion supporting said needle; and
[0180] - a second portion which is in contact with the cone, preferably with the undercut of the cone.
[0181] Item 11. The system according to Item 10, wherein the first part and the second part are preferably irreversibly connected by a snap-fit mechanism.
[0182] Item 12. A system according to Item 11, wherein the setting force of the second part of the adapter on the cone and / or the setting force of the adapter on the cone and / or the force of irreversibly connecting the first part and the second part through the snap-fit mechanism to reach the snap-fit point of the snap-fit mechanism is 10N to 300N, preferably 20N to 150N, and more preferably 50N to 120N.
[0183] Item 13. A system according to any one of Items 10 to 12, wherein the material of the second part includes or consists of a polymer.
[0184] Item 14. The system of any one of Items 10 to 13, wherein a sealing member is disposed between the first portion and the syringe barrel.
[0185] Item 15. A system according to Item 14, wherein the sealing member is in contact with the cone, preferably in contact with a terminal portion of the cone, which is located on the distal side of the syringe barrel.
[0186] Item 16. A system according to any one of Items 14 or 15, wherein the Shore A hardness of the sealing component measured for 10 seconds according to ASTM D2240:2021 is 20 to 80, preferably 30 to 70, more preferably 45 to 65, and more preferably 55 to 60.
[0187] Item 17. A system according to any one of Items 14 to 16, wherein the sealing member is at least partially compressed by the snap-fit mechanism, preferably at least partially compressed by 10% to 80%, preferably 20% to 70%, more preferably 30% to 60%, more preferably 40% to 50%.
[0188] Item 18. A system according to any one of Items 14 to 17, wherein the Young's modulus of the sealing member determined according to ISO 527-1 / -2:2019 is 0.1 MPa to 5 MPa, preferably 1 MPa to 4 MPa, and more preferably 1.5 MPa to 3 MPa.
[0189] Item 19. A system according to any one of Items 14 to 18, wherein the sealing member preferably has a thickness of 0.05 mm to 3.00 mm, preferably 0.5 mm to 2.50 mm, preferably 0.80 mm to 2.20 mm in its compressed state.
[0190] Item 20. The system according to any one of Items 14 to 19, wherein the material of the sealing member includes a polymer, preferably consists of a polymer, and the polymer is preferably an elastomer, more preferably a thermoplastic elastomer.
[0191] Item 21. A system according to any one of Items 1 to 13, wherein the second portion is a retaining portion.
[0192] Item 22. A system according to any one of items 1 to 13 or 21, wherein the second portion is substantially annular in shape, the annular shape is not completely closed and / or has a gap and / or its diameter can widen.
[0193] Item 23. A system according to any one of Items 1 to 13, 21 or 22, wherein the second portion is substantially annular in shape, and the annular shape applies a spring force in the direction of its central axis.
[0194] Item 24. A system according to any one of Items 1 to 13 or 21 to 23, wherein, after removal of the second part and elastic relaxation, the ratio of the inner circumference of the second part to the widest outer circumference of the cone is between 85% [mm / mm] and 99% [mm / mm] or between 90% [mm / mm] and 99% [mm / mm] when determined by measuring the inner diameter of the second part with the aid of a visual measuring device.
[0195] Item 25. A system according to any one of Items 1 to 13 or 21 to 24, wherein, after removal of the second part and elastic relaxation, the ratio of the inner circumference of the second part to the circumference of the bottom cut portion of the cone is 90% [mm / mm] to 107% [mm / mm] when determined by measuring the inner diameter of the second part with the aid of a visual measuring device.
[0196] Item 26. A system according to any one of Items 1 to 13 or 21 to 25, wherein the ratio of the radial force of the second part to the pull-off force of the adapter is 1% to 20,000% [N / N], preferably 2% to 5,000% [N / N], more preferably 5% to 200% [N / N], more preferably 10% to 100% [N / N], and more preferably 20% to 50% [N / N].
[0197] Item 27. A system according to any one of Items 1 to 13 or 21 to 25, wherein the radial force of the second part is 5N to 200N, preferably 10N to 180N, more preferably 20N to 150N, more preferably 30N to 120N, more preferably 40N to 100N, more preferably 50N to 80N.
[0198] Item 28. The system of any one of Items 1 to 13 or 21 to 27, wherein the pull-off force of the adapter is a tensile force of the second portion.
[0199] Item 29. A system according to any one of Items 1 to 13 or 21 to 28, wherein the material of the second part includes metal, preferably consists of metal, and the metal is preferably a metal including iron and / or aluminum, more preferably stainless steel.
[0200] Item 30. A system according to any one of Items 1 to 13 or 21 to 29, wherein the thickness of the second portion is 0.03 mm to 1 mm, preferably 0.05 mm to 0.8 mm, more preferably 0.1 mm to 0.4 mm, and more preferably 0.15 mm to 0.3 mm.
[0201] Item 31. A system according to any one of items 1 to 13 or 21 to 30, wherein the ratio of the Young's modulus [GPa] determined according to ISO 527-1 / -2:2019 to the thickness [mm] of the second part is 50 to 10,000 [GPa / mm], preferably 100 to 8,000 [GPa / mm], preferably 200 to 5,000 [GPa / mm], preferably 300 to 2,000 [GPa / mm], preferably 500 to 1,000 [GPa / mm].
[0202] Item 32. A system according to any one of Items 1 to 13 or 21 to 31, wherein the second part is completely surrounded by the first part, and / or the second part is embedded in the first part.
[0203] Item 33. A system according to any one of Items 1 to 13, wherein the cone and / or the second portion includes at least one area coated with a single layer or multiple layers of coating.
[0204] Item 34. A system according to Item 33, wherein the at least one region includes a conical region and / or an undercut portion of the cone, preferably includes the undercut portion, the conical region having the widest circumference of the cone.
[0205] Item 35. A system according to any one of Items 33 to 34, wherein the coating reduces surface defects on the cone and / or reduces impact when the second part is snapped onto the cone.
[0206] Item 36. A system according to any one of Items 33 to 35, wherein the coating comprises a polymer and / or a ceramic, the polymer being in particular an elastomer and / or a thermoplastic and / or a thermosetting plastic and / or a silicone.
[0207] Item 37. A system according to any one of Items 33 to 36, wherein the coating comprises nitrocellulose lacquer, polytetrafluoroethylene, silicone oil, silicone polymer, acrylic paint, (hydroxyethyl) methacrylate lacquer, shellac, epoxy resin and / or screen printing ink.
[0208] Item 38. A system according to any one of Items 33 to 37, wherein the thickness of the coating, preferably the average thickness, is 40nm to 200μm, preferably 70nm to 60μm, preferably 80nm to 50μm, preferably 90nm to 40μm.
[0209] Item 39. A system according to any one of Items 33 to 38, wherein the ratio of the pull-off force [N] to the thickness of the coating [nm] is 0.0004 to 8.75 [N / nm], preferably 0.0005 to 4 [N / nm], more preferably 0.0025 to 1 [N / nm], and more preferably 0.01 to 0.1 [N / nm].
[0210] Item 40. A system according to any one of Items 33 to 39, wherein the ratio of the hardness of the glass expressed in Young's modulus in MPa determined according to ISO 527-1 / -2:2019 to the hardness of the coating expressed in Young's modulus in MPa determined according to ISO 527-1 / -2:2019 is 4 to 10,000 [MPa / MPa], preferably 10 to 1,000 [MPa / MPa], preferably 20 to 500 [MPa / MPa], preferably 40 to 200 [MPa / MPa], and more preferably 60 to 100 [MPa / MPa].
[0211] Item 41. A system according to any one of Items 33 to 40, wherein the adhesion forces in the coating are less than the adhesion forces of the coating on a glass or polymer surface.
[0212] Item 42. A system according to any one of Items 33 to 41, wherein the thickness of the coating on the cone has a gradient in a direction along the cone.
[0213] Reference numerals
[0214] 1 Part 1
[0215] 2 Part 2
[0216] 3 Sealing component area
[0217] 4 Locking part
[0218] 5 Sealing components
[0219] 6-pin header
[0220] 7 Cone Area
[0221] 8 Undercut
[0222] 9 Shoulders
[0223] 10 Coating area of cone area
[0224] 11 Coating area of undercut
[0225] 12 lugs
[0226] 13 slots.
Claims
1. A system for long-term storage of a pharmaceutical composition, the system comprising: - a syringe barrel comprising: + Includes the front end of the cone; and +Backend; - a plunger inserted into said rear end; and - an adapter connected to said front end, the adapter comprising: + Needles; + an adapter body that connects the needle and the syringe barrel; and +optionally a needle shield covering the needle; in, - the pull-off force of the adapter measured according to ISO 11040-4:2015 Annex G.3 is between 1N and 500N; and - The cone breaking force measured according to ISO 11040-4:2015 Annex C.2 is 1 N or more and / or 400 N or less.
2. The system according to claim 1, wherein: - the pull-off force of the adapter measured according to ISO 11040-4:2015 Annex G.3 is 50N to 400N, preferably 60N to 300N, more preferably 70N to 250N, more preferably 80N to 200N, more preferably 85N to 150N; and / or - The cone breaking force measured according to ISO 11040-4:2015 Appendix C.2 is 5N or more, preferably 20N or more, more preferably 40N or more, more preferably 50N or more, more preferably 60N or more and / or 300N or less, preferably 200N or less, more preferably 150N or less.
3. The system according to claim 1 or 2, wherein: The system passed the container closure integrity test according to ISO 11040-4:2015 Annex H.
4. The system according to claim 3, wherein: The system passes the container closure integrity test according to ISO 11040-4:2015 Annex H after storage for 7 days, preferably 30 days, more preferably 100 days, more preferably 3 months, more preferably 6 months, more preferably 1 year, more preferably 2 years, more preferably 5 years under ambient conditions of 15°C-30°C or at 40°C±2°C and 75%±5% relative humidity.
5. A system according to any one of the preceding claims, wherein: - the syringe barrel comprises glass, preferably is made of glass; and / or - The adapter body comprises a polymer.
6. A system according to any one of the preceding claims, wherein: The syringe barrel comprises: - shoulders; and - wherein the cone comprises: + a conical region comprising the widest outer circumference of the cone; and + an undercut having an outer circumference smaller than the widest outer circumference of the cone, wherein preferably the undercut is located between the tapered area and the shoulder of the syringe barrel.
7. A system according to any one of the preceding claims, wherein: The adapter rotation resistance of the adapter on the cone is 0.03Nm to 1Nm, preferably 0.04Nm to 0.6Nm, preferably 0.05Nm to 0.4Nm, preferably 0.06Nm to 0.3Nm.
8. A system according to any one of the preceding claims, wherein: The adapter is anti-tilt mounted to the syringe barrel so that the central axis of the needle coincides with the central axis of the syringe barrel.
9. A system according to any one of the preceding claims, wherein: The needle is fixedly mounted or movably mounted in the adapter body.
10. A system according to any one of the preceding claims, wherein: The adapter body comprises: - a first portion supporting said needle; and - a second portion, which is in contact with said cone, preferably with said undercut of said cone.
11. The system according to claim 10, wherein: The first part and the second part are preferably irreversibly connected by a snap-fit mechanism.
12. The system according to claim 11, wherein: The setting force of the second part of the adapter on the cone and / or the setting force of the adapter on the cone and / or the force of irreversibly connecting the first part and the second part through the snap mechanism to reach the snap point of the snap mechanism is 10N to 300N, preferably 20N to 150N, more preferably 50N to 120N.
13. A system according to any one of claims 10 to 12, wherein: The material of the second portion includes or consists of a polymer.
14. A system according to any one of the preceding claims, wherein: The cone and / or the second portion comprises at least one area coated with a single-layer or multi-layer coating.
15. The system of claim 14, wherein: The at least one region comprises a conical region having the widest circumference of the cone and / or an undercut of the cone, preferably comprises the undercut.
16. A system according to any one of claims 14 or 15, wherein: The coating reduces surface defects on the cone and / or reduces impact when the second portion is snapped onto the cone.
17. A system according to any one of claims 14 to 16, wherein: The coating comprises a polymer and / or a ceramic, the polymer being in particular an elastomer and / or a thermoplastic and / or a thermosetting plastic and / or a silicone.
18. A system according to any one of claims 14 to 17, wherein: The coating includes nitrocellulose lacquer, polytetrafluoroethylene, silicone oil, silicone polymer, acrylic paint, (hydroxyethyl) methacrylate lacquer, shellac, epoxy resin and / or screen printing ink.
19. A system according to any one of claims 14 to 18, wherein: The coating has a thickness, preferably an average thickness, of 40 nm to 200 μm, preferably 70 nm to 60 μm, preferably 80 nm to 50 μm, preferably 90 nm to 40 μm.
20. A system according to any one of claims 14 to 19, wherein: The ratio of the pull-off force [N] to the thickness [nm] of the coating layer is 0.0004 to 8.75 [N / nm], preferably 0.0005 to 4 [N / nm], more preferably 0.0025 to 1 [N / nm], more preferably 0.01 to 0.1 [N / nm].
21. A system according to any one of claims 14 to 20, wherein: The ratio of the hardness of the glass expressed in Young's modulus in MPa determined according to ISO 527-1 / -2:2019 to the hardness of the coating expressed in Young's modulus in MPa determined according to ISO 527-1 / -2:2019 is 4 to 10,000 [MPa / MPa], preferably 10 to 1,000 [MPa / MPa], preferably 20 to 500 [MPa / MPa], preferably 40 to 200 [MPa / MPa], more preferably 60 to 100 [MPa / MPa].
22. A system according to any one of claims 14 to 21, wherein: The adhesion forces in the coating are less than the adhesion forces of the coating on glass or polymer surfaces.
23. A system according to any one of claims 14 to 22, wherein: The thickness of the coating on the cone has a gradient in a direction along the cone.
24. A system according to any one of claims 10 to 13, wherein: A sealing member is disposed between the first portion and the syringe barrel.
25. The system of claim 24, wherein: The sealing member is in contact with the cone, preferably with a terminal portion of the cone, which is located on the distal side of the syringe barrel.
26. A system according to any one of claims 24 or 25, wherein: The sealing member has a Shore A hardness of 20 to 80, preferably 30 to 70, more preferably 45 to 65, more preferably 55 to 60, measured for 10 seconds according to ASTM D2240:2021.
27. A system according to any one of claims 24 to 26, wherein: The sealing member is at least partially compressed by the snap-fit mechanism, preferably at least partially compressed by 10% to 80%, preferably 20% to 70%, more preferably 30% to 60%, more preferably 40% to 50%.
28. A system according to any one of claims 24 to 27, wherein: The Young's modulus of the sealing member determined according to ISO 527-1 / -2:2019 is 0.1 MPa to 5 MPa, preferably 1 MPa to 4 MPa, more preferably 1.5 MPa to 3 MPa.
29. The system according to any one of claims 24 to 28, wherein the sealing member preferably has a thickness in its compressed state of 0.05 mm to 3.00 mm, preferably 0.5 mm to 2.50 mm, preferably 0.80 mm to 2.20 mm.
30. A system according to any one of claims 24 to 29, wherein: The material of the sealing member comprises, preferably consists of, a polymer, preferably an elastomer, more preferably a thermoplastic elastomer.
31. A system according to any one of claims 1 to 13, wherein: The second portion is a retaining portion.
32. A system according to any one of claims 1 to 13 or 31, wherein: The second portion is substantially annular in shape, which is not completely closed and / or has a gap and / or whose diameter can widen.
33. A system according to any one of claims 1 to 13, 31 or 32, wherein: The second portion is substantially annular in shape, and the annular shape applies a spring force in the direction of its central axis.
34. A system according to any one of claims 1 to 13 or 31 to 33, wherein: After removal of the second part and elastic relaxation, the ratio of the inner circumference of the second part to the widest outer circumference of the cone is between 85% [mm / mm] and 99% [mm / mm] when determined by measuring the inner diameter of the second part with the aid of a visual measuring device.
35. A system according to any one of claims 1 to 13 or 31 to 34, wherein: After removal of the second part and elastic relaxation, the ratio of the inner circumference of the second part to the circumference of the undercut of the cone is 90% [mm / mm] to 107% [mm / mm], when determined by measuring the inner diameter of the second part with the aid of a visual measuring device.
36. A system according to any one of claims 1 to 13 or 31 to 35, wherein: The ratio of the radial force of the second portion to the pull-off force of the adapter is 1% to 20,000% [N / N], preferably 2% to 5,000% [N / N], more preferably 5% to 200% [N / N], more preferably 10% to 100% [N / N], more preferably 20% to 50% [N / N].
37. A system according to any one of claims 1 to 13 or 31 to 35, wherein: The radial force of the second portion is 5N to 200N, preferably 10N to 180N, more preferably 20N to 150N, more preferably 30N to 120N, more preferably 40N to 100N, more preferably 50N to 80N.
38. A system according to any one of claims 1 to 13 or 31 to 37, wherein: The pull-off force of the adapter is the pulling force of the second portion.
39. A system according to any one of claims 1 to 13 or 31 to 38, wherein: The material of the second part includes metal, preferably consists of metal, preferably a metal including iron and / or aluminum, more preferably stainless steel.
40. A system according to any one of claims 1 to 13 or 31 to 39, wherein: The thickness of the second portion is 0.03 mm to 1 mm, preferably 0.05 mm to 0.8 mm, more preferably 0.1 mm to 0.4 mm, more preferably 0.15 mm to 0.3 mm.
41. A system according to any one of claims 1 to 13 or 31 to 40, wherein: The ratio of the Young's modulus [GPa] determined according to ISO 527-1 / -2:2019 to the thickness [mm] of the second portion is 50 to 10,000 [GPa / mm], preferably 100 to 8,000 [GPa / mm], preferably 200 to 5,000 [GPa / mm], preferably 300 to 2,000 [GPa / mm], preferably 500 to 1,000 [GPa / mm].
42. A system according to any one of claims 1 to 13 or 31 to 41, wherein: The second part is completely surrounded by the first part, and / or the second part is embedded in the first part.
